VC firm

Spex Capital

Kingmaker Tier

Kingmaker Tier: 80 out of 100

Investor type: VC
Investing status: Activeas of 2026-09-18Source (opens in a new tab)
Headquarters: London, United Kingdom
Check size: We will invest between €500k - €2m at Seed or first ticket, up to €5m at Series A or second ticket, and could follow up at Series B for companies we know very well.Source (opens in a new tab)

Record updated 18 September 2026

About

Spex Capital is an investment management firm specialized in advancing disruptive early-stage ventures to deliver breakthroughs globally.

Thesis: From portfolio selection to exit strategies – we leverage our healthcare sector expertise across the entire investee company journey.Source (opens in a new tab)
Reserves policy: With a €100m fundraising target, Spex Capital can truly implement change in digital healthcare by investing in the most promising candidates with the pledge and capability to follow on with the more deserving companies during future rounds.
Eligibility: We look at target companies with “traction”. That can come in the form of contracts, revenues, studies and validations, partnerships and more.
Traction requirement: We look at target companies with “traction”. That can come in the form of contracts, revenues, studies and validations, partnerships and more.
Investing status notes: We are excited to announce the launch of our first Digital Technologies Fund, the Spex Venture Health-Tech Fund, a new €100M global fund devised to identify, partner with, and fund the next generation of early-stage digital healthcare and med-tech start-ups.

VC Catalog has relationship data for this record. Sign in with Google to explore it on the interactive map.